| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.25 | 8e-07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.26 | 8e-07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.26 | 5e-06 |